VERNON HILLS, Ill.--(BUSINESS WIRE)--Biopharmaceutical company Applied NeuroSolutions, Inc. (OTCBB:APNS)(www.appliedneurosolutions.com) today announced Dutton Associates, an independent research organization, upgraded its recommendation of the Company’s stock to “Strong Speculative Buy” from “Speculative Buy” and raised its 12-month price target to $1.00 a share from $0.50 a share.
